Trials / NCT01490827
Argus® II Retinal Prosthesis System Post-Market Surveillance Study
Terminated Observational Natural history / observational
Why it stopped: Sponsor discontinued the Argus II product
- Sponsor
- Second Sight Medical Products
- Treatment
- Not listed
- Gene
- Not stated
- Conditions
- Outer Retinal Degeneration, Retinitis Pigmentosa
- Ages
- 25 Years to no upper limit
- Enrollment
- 52 participants
- Started
- 2011-11
- Main results expected
- 2020-03-31
- Results posted
- Not yet
- Record last updated
- 2020-05-21
What the study is testing
This post-market surveillance study is conducted in the European Economic Area where Argus II has been CE certified for use in outer retinal degeneration patients.
Where it runs
Germany (8)
- Augenklinik des Staedtischen Klinikums, Karlsruhe, Baden-Wurttemberg
- Klinikum rechts der Isar - Technical University, Munich, Bavaria
- Center for Ophthalmology - University of Koln, Cologne, North Rhine-Westphalia
- Knappschaftsklinikum Saar, Department of Ophthalmology, Sulzbach, Saarland
- University Medical Center Schleswig-Holstein, Department of Ophthalmology, Lübeck, Schleswig-Holstein
- RWTH University Eye Clinic, Aachen
- University Hospital Hamburg-Eppendorf, Klinik u. Poliklinik fur Augenheilkunde, Hamburg
- Universitätsklinikum Leipzig AöR, Klinik und Poliklinik für Augenheilkunde, Leipzig
Italy (2)
- University of Pisa Eye Surgery Department, Pisa, Tuscany
- ULSS 15 Alta Padovana Hospital, Camposampiero, Veneto